[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-351475-105":59,"doc-detail-351475-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","amoeboidmesenchymal-transition-and-the-proteolytic-control-of-cancer-invasion-plasticity","Amoeboid–mesenchymal transition and the proteolytic control of cancer invasion plasticity","","Invasion plasticity enables malignant cells to switch between collective, mesenchymal, and amoeboid phenotypes while crossing extracellular matrix (ECM) barriers. Using cancer spheroid–3D matrix models, single-cell RNA sequencing, and human tissue explants, the study identifies mechanisms distinguishing mesenchymal versus amoeboid invasion. It finds that both collective/mesenchymal and amoeboid invasion programs rely on active tunneling with matrix-degradative metalloproteinase activity, specifically the membrane-anchored collagenase MMP14/MT1-MMP. CRISPR/Cas9 targeting of MMP14 abolishes tissue invasion in dense matrices and reveals nuclear integrity and DNA damage links. In live human breast tissue explants and patient samples, MMP14 expression aligns with proteolyzed type I collagen fragments, supporting a proteolytic requirement in vivo.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/amoeboidmesenchymal-transition-and-the-proteolytic-control-of-cancer-invasion-plasticity/351475/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/amoeboidmesenchymal-transition-and-the-proteolytic-control-of-cancer-invasion-plasticity/351475.png","ImageObject",300,407,{"name":92,"@type":93},"Jordan Avery","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-11","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",14,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What is invasion plasticity in cancer cells?","Question",{"text":113,"@type":114},"Invasion plasticity lets malignant cells toggle between collective, mesenchymal, and amoeboid phenotypes as they migrate through extracellular matrix (ECM) barriers.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How do mesenchymal and amoeboid invasion programs differ according to the study?",{"text":118,"@type":114},"They mobilize distinct transcriptional programs, but both activate comparable ECM-degradative proteolytic enzymes and show active tunneling through ECM barriers.",{"name":120,"@type":111,"acceptedAnswer":121},"Why is MMP14/MT1-MMP important for tissue invasion?",{"text":122,"@type":114},"CRISPR/Cas9 targeting of the membrane-anchored collagenase MMP14 eliminates invasive activity in dense matrices and is required again in live human breast tissue explants; human tumor analyses connect MMP14 expression with proteolyzed type I collagen fragments.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},351475,1790645675,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":41,"preview_page_count":19,"preview_urls":146},1099523882367,"https://ap-avatar.wpscdn.com/davatar_9964176cb1d06d4a9deccf72a44ae3dc","RESEARCH ARTICLE  \nCELL BIOLOGY  \n OPEN ACCESS  \nAmoeboid–mesenchymal transition and the proteolytic control of cancer invasion plasticity  \nAdam W. Olsona , Jonathan Lia , Xiao-Yan Lia , Lana Kinga , Long Jianga, Kalins Banerjeeb , Atticus J. McCoyc , Mahnoor N. Gondald,e,  \nArul M. Chinnaiyanf,g,h,i,j, Dorraya El-Ashryk, Evan T. Kellerb , Andrew J. Putnamc , and Stephen J. Weissa,1 Affiliations are included on p. 11.  \nEdited by Joan S. Brugge, Harvard Medical School, Boston, MA; received July 30, 2025; accepted February 3, 2026  \nInvasion plasticity allows malignant cells to toggle between collective, mesenchymal, and amoeboid phenotypes while traversing extracellular matrix (ECM) barriers. Current dogma holds that collective and mesenchymal invasion programs trigger the mobilization of proteinases that digest structural barriers dominated by type I collagen, while amoeboid activity allows cancer cells to marshal mechanical forces to traverse tissues independently of ECM proteolysis. Here, we use cancer spheroid-3-dimensional matrix models, single-cell RNA sequencing, and human tissue explants to identify the mechanisms controlling mesenchymal versus amoeboid invasion. Unexpectedly, collective/mesenchymal- and amoeboid-type invasion programs—though distinct—are each characterized by active tunneling through ECM barriers, with expression of matrix-degradative metalloproteinases. CRISPR/Cas9-mediated targeting of a single membrane-anchored collagenase, MMP14/MT1-MMP, ablates tissue-invasive activity while coregulating cancer cell transcriptional programs. Though changes in matrix architecture, nuclear rigidity, and metabolic stress as well as the presence of cancer-associated fibroblasts are proposed to support amoeboid activity, none of these changes restore invasive activity of MMP14-targeted cancer cells. While a requirement for MMP14 is bypassed in low-density collagen hydrogels, invasion by the proteinase-deleted cells is associated with nuclear envelope and DNA damage, highlighting a proteolytic requirement for maintaining nuclear integrity. Nevertheless, when cancer cells confront explants of live human breast tissue, MMP14 is again required to support invasive activity. Corroborating these results, spatial transcriptomic and immunohistological analyses of human breast cancers identified MMP14 expression in tissue-infiltrating carcinoma cells that were further juxtaposed with proteolyzed type I collagen fragments, underlining the pathophysiologic importance of this proteinase in directing invasive activity in vivo.  \ncancer | invasion | amoeboid | proteinase  \nInvasion plasticity is a hallmark of cancer cells capable of assuming collective, mesenchy mal, or amoeboid phenotypes as they infiltrate tissues ( 1–5) . Mesenchymal-type phenotypes, elicited by leader cells during collective invasion or individual cells during single-cell invasion, assume elongated shapes, while exerting contractile and protrusive forces on surrounding tissues (4, 6, 7) . By contrast, amoeboid phenotypes are characterized by spheroid-shaped cells that invade in a more fluid fashion as discrete single-cell units ( 1, 8, 9) . Independent of phenotype, tissue-invasive cancer cells are confronted by the extracellular matrix (ECM), a heterogeneous composite of structural proteins, proteoglycans, and glycosaminoglycans ( 10). Though complex, the ECM is dominated structurally by type I collagen, a triple-helical fibrillar protein that is deposited variably in a tissue-specific manner ( 11). Current dogma holds that mesenchymally invading cancer cells traverse ECM barriers by mobilizing proteolytic enzymes that actively degrade collagen-rich tissues (4, 12–14) . By contrast, amoeboid cancer cells are thought to navigate similar tissues in a proteinaseindependent fashion by using mechanical force to remodel the ECM, or alternatively, by distorting cell shape to infiltrate matrix pores ( 1, 4, 8, 15–18) .  \nHere, we characterize the requirements of mesen","cbCaiftj17SOtS86","https://ap.wps.com/l/cbCaiftj17SOtS86","pdf",30625151,12,"English","# Invasion plasticity and phenotypic modes\n## ECM barriers and prevailing mechanisms\n# Experimental strategy and key findings\n## Modeling invasion and profiling programs\n## MMP14 functional requirement\n# Implications for nuclear integrity and in vivo relevance\n## Human breast tissue and spatial analyses","[{\"question\":\"What is invasion plasticity in cancer cells?\",\"answer\":\"Invasion plasticity lets malignant cells toggle between collective, mesenchymal, and amoeboid phenotypes as they migrate through extracellular matrix (ECM) barriers.\"},{\"question\":\"How do mesenchymal and amoeboid invasion programs differ according to the study?\",\"answer\":\"They mobilize distinct transcriptional programs, but both activate comparable ECM-degradative proteolytic enzymes and show active tunneling through ECM barriers.\"},{\"question\":\"Why is MMP14/MT1-MMP important for tissue invasion?\",\"answer\":\"CRISPR/Cas9 targeting of the membrane-anchored collagenase MMP14 eliminates invasive activity in dense matrices and is required again in live human breast tissue explants; human tumor analyses connect MMP14 expression with proteolyzed type I collagen fragments.\"}]","Amoeboid–mesenchymal transition and the proteolytic control of cancer invasion plasticity | PDF",1790094338,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a1df2e502ab4ba2343ac88debe40d952.webp",983,1316,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0bdfdce2823b2ec9688127ba84e580b9.webp",982,1315,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/495b73b4fae77d99cfcca404fc36d89c.webp",981,1313,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/959ed701e1eb3a429549231f9748a689.webp",980,1312]